Thiomed 15mg (Thiotepa Vials) 15mg

Thiotepa works by alkylating DNA, which leads to cross-linking of DNA strands and inhibition of cell division. This process interferes with the replication and transcription of DNA, ultimately leading to cell death. It is particularly effective against rapidly dividing cells, such as those found in cancerous tumours.

The dosage of Thiomed 15mg is determined by a healthcare provider based on the patient's condition, response to treatment, and other factors. It is important to follow the prescribed dosage and administration guidelines to minimize risks and ensure effective treatment.

Use of Thiomed 15mg during pregnancy and breastfeeding should be avoided unless clearly necessary. Thiotepa can cause harm to a developing fetus or nursing infant. It is important to discuss the potential risks and benefits with a healthcare provider before using this medication.

To order Thiomed 15mg from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask the buyer to confirm trade or institutional credentials and will reply with pricing, availability, shipping (including cold-chain where relevant), and the import paperwork.

Thiomed 15mg is an alkylating agent that works by damaging the DNA of cancer cells. It is used in the treatment of various cancers and in preparation for bone marrow transplantation. Compared to other chemotherapy drugs, Thiotepa may have a different side effect profile and may be used in specific clinical situations where other drugs are not effective or appropriate.

Thiomed 15mg should be stored at 2-8°C, kept refrigerated, and protected from light. It should not be frozen or shaken. Proper handling and storage are important to maintain the efficacy and safety of the medication. Follow the storage instructions provided by the manufacturer and healthcare provider.

Thiomed 15mg is administered by a healthcare professional. It can be given intravenously, intramuscularly, or intravesically, depending on the condition being treated. The administration method and dosage are determined by a healthcare provider based on the patient's specific needs and response to treatment.

The most serious risks associated with Thiomed 15mg include bone marrow depression, septicaemia, haemorrhage, encephalopathy (high dose), secondary malignancies, hepatic veno-occlusive disease, and impaired fertility. Patients should be closely monitored for these and other potential side effects during treatment.

Thiomed 15mg should not be used by patients with a known hypersensitivity to Thiotepa or any of its components. It should also be used with caution in patients with existing bone marrow damage, a history of cardiac disease, prior radiation therapy, renal or hepatic impairment, and during pregnancy and breastfeeding. Always consult a healthcare provider before using this medication.